Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas: Variability and evolution.

Neurology - 15 Sept 2020

Throckmorton Patrick, Graber Jerome J

Abstract excerpt

OBJECTIVE: To assess the predictive value of T2 appearance as a defining criterion of T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign (T2FM), further characterize tumors that display the marker, and describe its radiographic evolution. METHODS: Records from 64 patients with astrocytomas were assessed for age at diagnosis, sex, tumor characteristics on pretreatment CT, MRI, and pathology,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Imaging

Share to Mutation

Source

Identifiers

PMID: 32690782
DOI: 10.1212/WNL.0000000000010324

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas: Variability and evolution.PMID 32690782Read ↗

"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.Semantic proximity Read ↗

T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.Semantic proximity Read ↗

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.Semantic proximity Read ↗

T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant.Semantic proximity Read ↗

The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.Semantic proximity Read ↗

T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant Astrocytomas.Semantic proximity Read ↗

Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.Semantic proximity Read ↗

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.Semantic proximity Read ↗

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.Semantic proximity Read ↗

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas.Semantic proximity Read ↗

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.Semantic proximity Read ↗

T2-FLAIR Mismatch Positive IDH-mutant Astrocytomas: Can We Identify High-grade Tumors Among them Before Surgery?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.